Publications

Search by keyword

Type

Member

featured publications

Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

21/03/2019 Journal of medicinal chemistry

Authors: Charlotte A Bäuml, Thomas Schmitz, Ajay Abisheck Paul George, Monica Sudarsanam, Kornelia Hardes, Torsten Steinmetzer, Lori A Holle, Alisa S Wolberg, Bernd Pötzsch, Johannes Oldenburg, Arijit Biswas, Diana Imhof
View this publication
Rapid and sustained immune tolerance to inhibitors induced by a plasma-derived, VWF-containing FVIII concentrate.

20/02/2019 Haemophilia : the official journal of the World Federation of Hemophilia

Authors: Elena Santagostino, Savita Rangarajan, Johannes Oldenburg, Roser Peiró-Jordan, Víctor Jiménez-Yuste
View this publication
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.

06/02/2019 Haemophilia : the official journal of the World Federation of Hemophilia

Authors: Rebecca Kruse-Jarres, Johannes Oldenburg, Elena Santagostino, Midori Shima, Christine L Kempton, Craig M Kessler, Michaela Lehle, Sammy Chebon, Nives Selak Bienz, Elina Asikanius, Johnny Mahlangu
View this publication
Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.

05/02/2019 Hamostaseologie

Authors: Martin Olivieri, Christoph Königs, Christine Heller, Silvia Horneff, Johannes Oldenburg, Susan Halimeh, Karim Kentouche, Ralf Knöfler, Lars Fischer, Christian Pfrepper, Karin Kurnik, Christoph Bidlingmaier
View this publication
Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

31/01/2019 Haematologica

Authors: Yohann Repessé, Catherine Costa, Roberta Palla, Elika Farrokhi Moshai, Annie Borel-Derlon, Roseline D'Oiron, Chantal Rothschild, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Johannes Oldenburg, Anna Pavlova, Frits R Rosendaal, Flora Peyvandi, Srinivas V Kaveri, Sébastien Lacroix-Desmazes
View this publication
Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol.

29/01/2019 Haemophilia : the official journal of the World Federation of Hemophilia

Authors: Stefan Schlabe, Kathrin van Bremen, Georg Goldmann, Johannes Oldenburg, Anna-Maria Eis-Hübinger, Heike Zeitler, Ulrich Spengler
View this publication

First page
13
14
15
16
17
18
19
20
21
22

Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.

Rapid and sustained immune tolerance to inhibitors induced by a plasma-derived, VWF-containing FVIII concentrate.

Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.

Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol.